Investorideas.com - BioSante Pharmaceuticals (NASDAQ: BPAX) Company Profile at Investorideas.com
BioSante is focused on developing innovative products for female sexual health and oncology
Subscribe to Investor Ideas Newswire
Visit this company: www.biosantepharma.com
August 24, 2010 - (Investorideas.com newswire) www.InvestorIdeas.com, an investor research portal covering multiple sectors including biotech stocks and pharma stocks, announces the new company profile for pharma stock BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) for interested investors.
BioSante (NASDAQ: BPAX ) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment, and Elestrin™ (estradiol gel) for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, which is marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines (GVAX), three of which have been granted orphan drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism, licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is developing its calcium phosphate technology (CaP) for aesthetic medicine (BioLook™), among other uses, as well as seeking opportunities for its 2A/Furin and other technologies.
Visit BioSante’s profile on Investorideas.com: http://www.investorideas.com/CO/BPAX/ or visit the BioSante website at www.biosantepharma.com to learn more about BioSante.
Request News & Updates from BioSante (NASDAQ: BPAX) on the Investorideas.com sign up page: http://www.investorideas.com/Resources/Newsletter.asp
About our Biotech/Pharma Stocks portal:
BiotechIndustryStocks.com Portal is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.Visit the Biotech stocks Directory
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing covering over thirty industry sectors and global markets including China, India, the Middle East and Australia.
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) was brought to Investorideas.com by Money Channel TV http://www.moneychannel.tv/. The Money Channel’s "Steve Crowley's American Scene" was launched from the Disney/MGM Radio Studios at the Walt Disney World Resort in June 1990. The American Scene has millions of listeners on its three-hour daily radio broadcasts through the mighty IRN/USA Radio Network affiliates, plus other affiliates. There also is a growing listening audience on the Internet worldwide. In addition in The Money Channel produces WallStreetCast, a half hour program airing on FOX Business. WallStreetCast has highlighted some of today’s top experts and advisors from Wall Street and some of the best public companies in the market. Steve Crowley interviews top experts, analysts, money managers and authors covering stocks, investments, business, the economy and trends, Small-Cap CEOs and much more. More than 200 Financial “Stars” are interviewed in constant rotation….from Steve Forbes, Tobin Smith, Beth Dater, Joe Battipaglia, Larry Kudlow plus many more.
Disclaimer: The BioSante Pharmaceuticals, Inc company profile is a paid for submission profile. Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions, company profile submissions and online advertising. http://www.investorideas.com/About/Disclaimer.aspDisclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For information about BioSante Pharmaceuticals, Inc.Contact:
The Trout Group LLCTricia Swanson(646) 378-2953; email@example.com
For Additional Information about Investorideas.com:
C Van Zant: 800-665-0411 – firstname.lastname@example.org
Source – Investorideas.com